Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 7, 2020 8-K
8-K Apr 27, 2020 8-K
EFFECT Apr 14, 2020
CORRESP Apr 10, 2020
DEFA14A Apr 10, 2020 DEFA14A
DEF 14A Apr 10, 2020 DEF 14A
UPLOAD Apr 1, 2020
PRE 14A Mar 27, 2020 PRE 14A
S-3 Mar 26, 2020 S-3
4 Mar 17, 2020 FORM 4 SUBMISSION
S-8 Mar 13, 2020 S-8
10-K Mar 13, 2020 10-K
8-K Mar 11, 2020 8-K
8-K Feb 19, 2020 8-K
SEC STAFF LETTER Feb 18, 2020
4 Feb 14, 2020 FORM 4 SUBMISSION
4 Feb 14, 2020 FORM 4 SUBMISSION
4 Feb 14, 2020 FORM 4 SUBMISSION
5 Feb 13, 2020 FORM 5 SUBMISSION
SC 13G/A Feb 13, 2020 DECEMBER 31, 2019
424B5 Feb 7, 2020 424B5
8-K Feb 7, 2020 8-K
SEC STAFF LETTER Feb 6, 2020
424B5 Feb 6, 2020 424B5
8-K Feb 6, 2020 8-K
← Newer Page 19 of 33 · 819 filings Older →